CN113387991B - Method for synthesizing dydrogesterone and compound - Google Patents
Method for synthesizing dydrogesterone and compound Download PDFInfo
- Publication number
- CN113387991B CN113387991B CN202010175402.0A CN202010175402A CN113387991B CN 113387991 B CN113387991 B CN 113387991B CN 202010175402 A CN202010175402 A CN 202010175402A CN 113387991 B CN113387991 B CN 113387991B
- Authority
- CN
- China
- Prior art keywords
- acid
- dydrogesterone
- methyl
- photochemical reaction
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JGMOKGBVKVMRFX-HQZYFCCVSA-N dydrogesterone Chemical compound C1=CC2=CC(=O)CC[C@@]2(C)[C@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 JGMOKGBVKVMRFX-HQZYFCCVSA-N 0.000 title claims abstract description 25
- 229960004913 dydrogesterone Drugs 0.000 title claims abstract description 25
- 150000001875 compounds Chemical class 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 title abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 13
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 230000003647 oxidation Effects 0.000 claims abstract description 8
- 238000005286 illumination Methods 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 13
- 238000006552 photochemical reaction Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- 150000003431 steroids Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- MDDPTCUZZASZIQ-UHFFFAOYSA-N tris[(2-methylpropan-2-yl)oxy]alumane Chemical compound [Al+3].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] MDDPTCUZZASZIQ-UHFFFAOYSA-N 0.000 claims description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 238000006327 primary photochemical reaction Methods 0.000 claims description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 35
- 239000002994 raw material Substances 0.000 abstract description 8
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000013032 photocatalytic reaction Methods 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 3
- 238000010511 deprotection reaction Methods 0.000 abstract description 2
- 238000006462 rearrangement reaction Methods 0.000 abstract description 2
- 230000007306 turnover Effects 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 238000005406 washing Methods 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 11
- 229910052753 mercury Inorganic materials 0.000 description 11
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 4
- 239000012043 crude product Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- -1 ethylene, propylene Chemical group 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000000583 progesterone congener Substances 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000005388 borosilicate glass Substances 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000007256 debromination reaction Methods 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 2
- QTVNPWWLYMFLEI-UHFFFAOYSA-N 1-(3-hydroxy-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl)ethanone Chemical compound C1C(O)CCC2(C)C(CCC3(C(C(=O)C)CCC33)C)C3=CC=C21 QTVNPWWLYMFLEI-UHFFFAOYSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 238000006859 Swern oxidation reaction Methods 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- VYIIGPBTHBMATO-NCUVAXEISA-N [(9s,10r,13s,14r,17s)-17-acetyl-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H](C(C)=O)CC[C@H]3C1=CC=C1[C@]2(C)CCC(OC(=O)C)C1 VYIIGPBTHBMATO-NCUVAXEISA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention provides a method for synthesizing dydrogesterone, which takes dehydropregnenolone as a starting material to prepare carbonyl-protected dehydropregnenolone, then obtains a methyl configuration turnover compound through a photocatalytic reaction, and further obtains dydrogesterone through deprotection, hydroxyl oxidation and double bond rearrangement reaction. The method has the advantages of easily obtained raw materials, high yield, simple and mild reaction conditions and suitability for industrial production of dydrogesterone.
Description
Technical Field
The invention belongs to the field of medicine synthesis, and in particular relates to a novel synthesis method of dydrogesterone.
Background
Dydrogesterone is an artificially synthesized progestogen, can be used for treating diseases caused by endogenous progesterone deficiency, such as dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycle, dysfunctional uterine bleeding, premenstrual syndrome, threatened abortion or habitual abortion caused by progestogen deficiency and infertility caused by corpus luteum deficiency, and is a relatively ideal progestogen medicine at present.
Literature Recueil des Travaux Chimiques des Pays-Bas (1961), 80:43-46 reports that 3-hydroxy-pregna-5, 7-dien-20-one is used as a raw material, a steroid B switching ring reaction is carried out in tetrahydrofuran by using a high-pressure mercury lamp to complete the inversion of a 10-position angle methyl by configuration isomerization, and dydrogesterone is obtained by Wolff oxidation and rearrangement of a product. In the illumination step, a large amount of tetrahydrofuran is used, a large amount of raw materials remain, the yield of the whole illumination is only 10.6%, and the raw material sources of subsequent reactions and the efficiency of the whole production process are severely restricted.
Literature Recueil des Travaux Chimiques des Pays-Bas (1971), 90:27-32 reports the route to dydrogesterone starting from progesterone by glycol protection, bromination, debromination, rearrangement by high-pressure mercury lamp illumination. The protection yield of the glycol in the route is low (32% -67%The Journal of Organic Chemistry,1952,vol.17,p.1369,1373), the bromination and debromination have a lot of isomerism, so that the two-step yield is low (49%), the yield is only 22% in the key illumination step, and the industrialization is very difficult.
The Chinese patent (CN 102558272B) published in 2014 reports that the total conversion rate of the illumination raw materials is 35.4-44.6% and the total photochemical yield is 35.8-41.6% based on the route of the double-ketal inward-immersion uplink bubbling double-filtering system in the department of academy of physics and chemistry.
Published chinese patent CN103848880 a in 2014 was also optimized for this route in the institute of physics and chemistry of the chinese academy of sciences on the reaction apparatus. They used a dual wavelength microfluidics technique with a highest overall photochemical yield of 46.3%
2008 Disclosed in patent CN101318982A Taizhou Wanfu pharmaceutical Co., ltd. With 3-acetoxy-pregna-5, 7-dien-20-one, the photochemical reaction yield is relatively low (30-35%), probably because Norrish I and/or Norrish II reactions (modern molecular photochemistry Wuzhu Zhenge, etc.) occur in carbonyl groups in the molecule, so that the illuminated product impurities are increased, and the yield of the target product is relatively low.
Thus, the efficient preparation of intermediates for the isomerisation of the 10-position angle methyl configuration is a core and key step in the industrial production of dydrogesterone, and the preparation of such intermediates in high yields and high purity still requires further exploration.
Disclosure of Invention
The invention provides a novel synthesis method of dydrogesterone, which can efficiently synthesize dydrogesterone and powerfully solve the defects in the route.
The invention takes dehydropregnenolone as a starting material (DG-7) to prepare carbonyl-protected dehydropregnenolone (DG-8), then a methyl configuration turnover compound DG-9 is obtained through a photocatalytic reaction, DG-9 is deprotected to obtain DG-10, DG-10 is subjected to hydroxyl oxidation to obtain ketene DG-11, and double bond rearrangement is carried out under the acidic condition of DG-11 to obtain dydrogesterone.
The synthesis route of dydrogesterone is as follows:
Wherein R 1、R2 are the same or different and are alkyl groups, optionally R 1、R2 may be terminally linked.
As one embodiment, R 1、R2 is the same or different and is C1-C5 alkyl, such as methyl, ethyl, etc., preferably methyl.
As one embodiment, R 1、R2 is the same or different and is C1-C5 alkyl and R 1、R2 is linked at the tail end, such as ethylene, propylene, preferably ethylene.
In the step a, the DG-7 is carbonyl protected under the catalysis of acid to obtain ketal DG-8, wherein the acid is protonic acid or Lewis acid, and comprises hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, perchloric acid, trifluoroacetic acid, trifluoromethanesulfonic acid, toluenesulfonic acid, methanesulfonic acid, benzenesulfonic acid, ferric trichloride, aluminum trichloride, zinc chloride and the like; preferably, the acid is p-toluene sulfonic acid or p-toluene sulfonic acid.
In the step B, DG-8 is subjected to a photochemical reaction at first to finish the opening of the bonds at the 9 and 10 positions of the steroid B ring; and then, closing the 9 and 10-position bonds of the ring of the steroid B through secondary photochemical reaction to obtain 10-position angle methyl isomerism DG-9.
Preferably, the primary photochemical reaction selects light with the wavelength of 200-300 nm for illumination, and the secondary photochemical reaction selects light with the wavelength of 310-400 nm for illumination. Illumination for the photochemical reaction is preferably provided by a high pressure mercury lamp with a power of 500-1000 watts.
In step b, the solvent is preferably ethanol, DG-8: the weight-volume ratio of the ethanol is 1:100-1000.
In step d, DG-10 is oxidized by hydroxyl groups to give ketene DG-11. The hydroxyl oxidation reaction is carried out under the conditions of dessert oxidation, aluminum alkoxide oxidation, swern oxidation and the like, and preferably, the oxidant for hydroxyl oxidation is dessert or aluminum alkoxide.
In step e, DG-11 is double bond rearranged under acidic conditions to give dydrogesterone.
In another aspect, the present invention provides a class of intermediate compounds DG-8 and DG-9, which have the following structures:
wherein R1 and R2 are defined as above.
The intermediate compounds may be used in the preparation of dydrogesterone.
In summary, the present invention provides a novel synthesis method of dydrogesterone, which uses dehydropregnenolone as a starting material (DG-7) to prepare carbonyl-protected dehydropregnenolone (DG-8), then a methyl configuration inversion compound DG-9 is obtained through a photocatalytic reaction, and dydrogesterone is obtained through deprotection, hydroxyl oxidation and double bond rearrangement reaction of DG-9. The method has the advantages of easily obtained raw materials, high yield, simple and mild reaction conditions and suitability for industrial production of dydrogesterone.
As the core and key steps of the whole route, photochemical conversion in the DG-9 preparation process determines the efficiency of the whole production process, and by adopting the method, the photochemical conversion rate and selectivity are greatly improved, the total yield is improved to more than 60%, the total yield is far higher than that reported in the current literature, the illumination yield is low, the product purity is high, the problems of more impurities, incomplete ring opening, more ring closing impurities and the like are solved, and the whole route is a very efficient and simple route and is very suitable for industrial production.
Detailed Description
In order that those skilled in the art can better understand the present invention, the following description of the technical solution of the present invention will be given by way of specific examples. It is to be understood that the following examples are given only for better illustration of the present invention and are not to be construed as limiting the present invention.
Synthesis of DG-8 series Compounds
Example 1:
500g DG-7, 500g ethylene glycol, 500g triethyl orthoformate, 5g p-toluenesulfonic acid and 5000ml methylene dichloride are added into a reaction bottle, the reaction is completed by stirring at room temperature, 1000ml water is added, the mixture is stirred, then the mixture is kept stand for liquid separation, and the organic phase is concentrated under reduced pressure to obtain solid DG-8.1, and the yield is 95.2%.
ESI-HRMS theory: c 23H34O3[M+H]+ 359.2508, found 359.2510.
1H-NMR(δ,ppm,CDCl3):5.70-5.55(m,1H);5.39-5.38(m,1H);4.02-3.84(m,4H);3.66-3.59(m,1H);2.48-2.43(m,1H);2.30-2.24(m,1H);2.16-2.12(m,1H);1.98-1.94(m,1H);1.89-1.87(m,4H);1.83-1.66(m,4H);1.61-1.53(m,1H);1.51-1.41(m,2H);1.32-1.22(m,5H);0.94(s,3H);0.71(s,3H).
Example 2:
500g DG-7, 114g triethyl orthoformate, 1.4g p-toluenesulfonic acid and 540mL methanol are added into a reaction bottle to react for three hours at 50-60 ℃, the mixture is decompressed, 500mL ethyl acetate is added for extraction, then 500mL saturated sodium bicarbonate is used for washing, 500mL saturated saline solution is used for washing, anhydrous sodium sulfate is used for drying, filtration and concentration are carried out, and DG-8.2 is obtained, and the yield is 93.7%.
ESI-HRMS theory: c 23H36O3[M+H]+ 361.2664, found 361.2669.
1H-NMR(δ,ppm,CDCl3):5.74-5.58(m,1H);5.40-5.37(m,1H);4.05(s,3H);3.84(s,3H);3.70-2.45(m,2H);2.29-1.92(m,3H);1.90-1.86(m,4H);1.72-1.67(m,4H);1.60-1.43(m,3H);1.35-1.19(m,5H);0.89(s,3H);0.74(s,3H).
Synthesis of Compound DG-9 series
Example 3:
100g DG-8.1 and 100g triethylamine are added into 10L absolute ethyl alcohol, and after stirring and dissolving, 0.5g 2, 6-di-tert-butyl-p-cresol is added, and an internal illumination photochemical reactor with quartz cold hydrazine (the transmission wavelength is 200-300 nm) is added. Stirring, controlling the temperature to 10-15 ℃, circulating the refrigerating fluid, and starting a 500W high-pressure mercury lamp to irradiate for 8 hours. Turning off a high-pressure mercury lamp, filtering the reaction solution, collecting filtrate, adding the filtrate into an internal irradiation photochemical reactor with high borosilicate glass cold hydrazine (with the transparent wavelength of 310-400 nm), turning on stirring, turning on a 500W high-pressure mercury lamp to irradiate for 16 hours, turning off the high-pressure mercury lamp, concentrating the reaction solution at 35 ℃ under reduced pressure, and freezing and crystallizing to obtain white solid DG-9.1 with the purity of 99.3% and the yield of 70.6%.
ESI-HRMS theory: c 23H34O3[M+H]+ 359.2508, found 359.2511.
1H-NMR(δ,ppm,CDCl3):5.67-5.65(m,1H);5.45-5.44(m,1H);4.09-4.08(m,1H);4.02-3.92(m,2H);3.90-3.82(m,2H);2.56-2.45(m,2H);2.29-2.24(m,2H);2.11-1.99(m,1H);1.82-1.74(m,4H);1.68-1.61(m,3H);1.57-1.40(m,4H);1.30(s,3H);0.73(s,3H);0.71(s,3H).
Example 4:
100g DG-8.2 and 100g triethylamine are added into 15L absolute ethyl alcohol, then 0.5g 2, 6-di-tert-butyl-p-cresol is added into the mixture, and an internal illumination photochemical reactor with quartz cold hydrazine (the transmission wavelength is 200-300 nm) is added into the mixture. Stirring, controlling the temperature to 10-15 ℃, circulating the refrigerating fluid, and starting a 1000W high-pressure mercury lamp to irradiate for 12 hours. Turning off a high-pressure mercury lamp, filtering the reaction solution, collecting filtrate, adding the filtrate into an internal irradiation photochemical reactor with high borosilicate glass cold hydrazine (with the transparent wavelength of 310-400 nm), turning on stirring, turning on a 1000W high-pressure mercury lamp for irradiation for 20 hours, turning off the high-pressure mercury lamp, concentrating the reaction solution at 35 ℃ under reduced pressure, and freezing for crystallization to obtain white solid DG-9.2 with the purity of 99.2% and the yield of 67.4%.
ESI-HRMS theory: c 23H36O3[M+H]+ 361.2664, found 361.2661.
1H-NMR(δ,ppm,CDCl3):5.72-5.69(m,1H);5.49-5.46(m,1H);4.11-4.09(m,1H);3.98(s,3H);3.88(s,3H);2.60-2.44(m,2H);2.27-1.96(m,3H);1.85-1.77(m,4H);1.70-1.65(m,3H);1.59-1.51(m,4H);1.37(s,3H);0.79(s,3H);0.69(s,3H).
Comparative example 1:
Referring to the reaction conditions of example 3, DG-10 as a white solid was obtained in a purity of 68.4% and a yield of 12.6%.
ESI-HRMS theory: c 21H30O2[M+H]+ 315.2246, found 315.2247.
Synthesis of Compound DG-10
Example 5:
143g DG-9.1 was added to the reaction flask, and 1000mL THF was dissolved with stirring. The reaction temperature is controlled to be 0 ℃ by using a low-temperature bath, 1N HCl aqueous solution is added, the reaction is continued for 16 hours under the condition that the temperature is unchanged, the point plate raw materials are completely reacted, ethyl acetate is added for dilution, water washing, saturated sodium bicarbonate aqueous solution water washing, saturated salt water washing, anhydrous sodium sulfate drying and concentration are carried out, and the ethyl acetate is used for obtaining the compound DG-10, and the yield is 85.6%.
ESI-HRMS theory: c 21H30O2[M+H]+ 315.2246, found 315.2249.
1H-NMR(δ,ppm,CDCl3):5.68-5.66(m,1H);5.49-5.48(m,1H);4.11-4.10(m,1H);2.75-2.63(m,2H);2.50-2.46(m,1H);2.31-2.23(m,4H);2.14(s,3H);1.81-1.49(m,10H);0.76(s,3H);0.57(s,3H).
Example 6:
20g DG-9.2 was added to the reaction flask, and 100mL of acetone was added thereto, followed by stirring and dissolution. Adding 2.1g of p-toluenesulfonic acid, reacting for 1 hour at room temperature, completely reacting the plate raw material, adding ethyl acetate for dilution, washing with water, washing with saturated sodium bicarbonate water solution, washing with saturated saline water, drying with anhydrous sodium sulfate, concentrating, and performing column chromatography to obtain the compound DG-10 with a yield of 86.4%.
ESI-HRMS theory: c 21H30O2[M+H]+ 315.2246, found 315.2246.
Synthesis of Compound DG-11
Example 7:
59g DG-10, 500mL toluene, 168g cyclohexanone and 23g aluminum triisopropoxide were added to the reaction flask. The reaction was heated to reflux for 1 hour and then returned to ambient temperature. Adding ethyl acetate for dilution, quenching with concentrated hydrochloric acid for reaction, washing with water, saturated saline water, drying with anhydrous sodium sulfate, concentrating, and performing column chromatography to obtain the product DG-11 with a yield of 75.4%.
ESI-HRMS theory: C21H28O2[ M+H ] +313.2089, found 313.2093.
1H-NMR(δ,ppm,CDCl3):5.82-5.81(m,1H);5.29-5.27(m,1H);3.02-2.93(m,2H);2.67-2.63(m,1H);2.46-2.32(m,3H);2.18-2.16(m,3H);2.14(s,3H);1.99-1.96(m,1H);1.55-1.80(m,6H);1.43-1.39(m,1H);1.07(s,3H);0.61(s,3H).
Example 8:
To the reaction flask was added 20g DG-10, 300mL toluene, 90g cyclohexanone and 15g aluminum tri-tert-butoxide. The reaction was heated to reflux for 2.5 hours and then returned to ambient temperature. Adding ethyl acetate for dilution, quenching with concentrated hydrochloric acid for reaction, washing with water, saturated saline water, drying with anhydrous sodium sulfate, concentrating, and performing column chromatography to obtain the product DG-11 with a yield of 78.2%.
ESI-HRMS theory: C21H28O2[ M+H ] +313.2089, found 313.2096.
Example 9:
To the reaction flask were added 40g DG-10, 420mL toluene, 120g cyclohexanone and 20g aluminum tri-tert-butoxide. The reaction was heated to reflux for 3 hours and then returned to ambient temperature. Adding ethyl acetate for dilution, quenching with concentrated hydrochloric acid for reaction, washing with water, saturated saline water, drying with anhydrous sodium sulfate, concentrating, and performing column chromatography to obtain the product DG-11 with a yield of 73.6%.
ESI-HRMS theory: C21H28O2[ M+H ] +313.2089, found 313.2086.
Synthesis of dydrogesterone
Example 10:
To a 1L reaction flask was added 50gDG-11, 500ml of 31.5% HCl/iPrOH solution and the reaction was completed at room temperature. Adding saturated sodium bicarbonate water solution for quenching, extracting with ethyl acetate, washing with water, saturated saline water washing, drying with anhydrous sodium sulfate, concentrating, recrystallizing the crude product with acetone and n-hexane to obtain dydrogesterone with yield of 85.3% and HPLC purity of 99.1%.
ESI-HRMS theory: c 21H28O2[M+H]+ 313.2089, found 313.2087.
1H-NMR(δ,ppm,CDCl3):6.20-6.14(m,2H);5.68(s,1H);2.60-2.52(m,2H);2.60-2.52(m,2H);2.48-2.40(m,2H);2.31-2.17(m,2H);2.13(s,3H);2.03-1.95(m,2H);1.88-1.80(m,2H);1.79-1.62(m,3H);1.40-1.18(m,6H);0.71(s,3H).
Example 11:
To a 1L reaction flask was added 20gDG-11, 300ml 33% HCl/MeOH solution and the reaction was completed at room temperature. Adding saturated sodium bicarbonate water solution for quenching, extracting with ethyl acetate, washing with water, saturated saline water washing, drying with anhydrous sodium sulfate, concentrating, and recrystallizing the crude product with acetone and n-hexane to obtain dydrogesterone with a yield of 84.6% and an HPLC purity of 99.2%.
ESI-HRMS theory: c 21H28O2[M+H]+ 313.2089, found 313.2094.
Example 12:
10gDG-11, 100ml of 33% HBr/HOAc solution were added to a 1L reaction flask and reacted to completion at 0 ℃. Pouring the system into ice water to separate out a large amount of solids, filtering, washing a filter cake with water, washing with saturated sodium bicarbonate water solution, pumping, recrystallizing a crude product with acetone and n-hexane to obtain dydrogesterone, wherein the yield is 86.3%, and the HPLC purity is 99.2%.
ESI-HRMS theory: c 21H28O2[M+H]+ 313.2089, found 313.2092.
Claims (9)
1. A method for preparing dydrogesterone, which comprises the following steps:
Wherein R 1、R2 is methyl or ethyl, optionally the tail end of R 1、R2 is attached;
In the step B, DG-8 is first photochemistry reacted to complete the opening of 9 and 10 position bonds of steroid B ring, and then secondary photochemistry reacted to close the 9 and 10 position bonds of steroid B ring to obtain 10 position angle methyl isomerism DG-9.
2. The method of manufacturing according to claim 1, characterized in that: and R 1、R2 is methyl.
3. The method of manufacturing according to claim 1, characterized in that: in step a, DG-7 is carbonyl-protected under the catalysis of an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, perchloric acid, trifluoroacetic acid, trifluoromethanesulfonic acid, toluenesulfonic acid, methanesulfonic acid, benzenesulfonic acid, ferric trichloride, aluminum trichloride, and zinc chloride to give ketal DG-8.
4. The method of manufacturing according to claim 1, characterized in that: the first photochemical reaction selects light with the wavelength of 200-300 nm for illumination, and the second photochemical reaction selects light with the wavelength of 310-400 nm for illumination.
5. The method of manufacturing according to claim 1, characterized in that: in the step d, DG-10 is subjected to hydroxyl oxidation to obtain ketene DG-11, and the oxidant for the hydroxyl oxidation reaction is aluminum triisopropoxide or aluminum tri-tert-butoxide.
6. The method of manufacturing according to claim 1, characterized in that: in step e, DG-11 is double bond rearranged under acidic conditions to give dydrogesterone.
7. A compound having the structure:
Wherein R 1、R2 is methyl or ethyl, optionally the tail end of R 1、R2 is attached.
8. The process for preparing compound DG-9 according to claim 7, wherein the process comprises the steps of carrying out a photochemical reaction on DG-8 to open bonds at positions 9 and 10 of steroid B ring, and then carrying out a secondary photochemical reaction to close bonds at positions 9 and 10 of steroid B ring to obtain 10-bit angle methyl isomerised DG-9.
9. The method of manufacturing according to claim 8, wherein: the primary photochemical reaction selects light with the wavelength of 200-300 nm for illumination, and the secondary photochemical reaction selects light with the wavelength of 310-400 nm for illumination.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010175402.0A CN113387991B (en) | 2020-03-13 | 2020-03-13 | Method for synthesizing dydrogesterone and compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010175402.0A CN113387991B (en) | 2020-03-13 | 2020-03-13 | Method for synthesizing dydrogesterone and compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113387991A CN113387991A (en) | 2021-09-14 |
| CN113387991B true CN113387991B (en) | 2024-06-18 |
Family
ID=77615993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010175402.0A Active CN113387991B (en) | 2020-03-13 | 2020-03-13 | Method for synthesizing dydrogesterone and compound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113387991B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023035906A1 (en) * | 2021-09-08 | 2023-03-16 | 湖南醇康医药科技有限公司 | Intermediate compound and preparation method therefor and application thereof |
| CN114437164B (en) * | 2022-01-26 | 2024-01-30 | 西安国康瑞金制药有限公司 | Dydrogesterone and preparation method thereof |
| CN116606341A (en) * | 2022-07-28 | 2023-08-18 | 上海醇健实业发展有限公司 | Steroid compound for treating central nervous system diseases, preparation method, application and pharmaceutical composition thereof |
| CN116120387B (en) * | 2023-02-08 | 2025-04-11 | 湖南新合新生物医药有限公司 | A kind of synthesis process of dydrogesterone |
| CN116239645B (en) * | 2023-03-16 | 2024-09-17 | 广西金源生物化工实业有限公司 | Synthesis method of dydrogesterone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101318982A (en) * | 2007-08-03 | 2008-12-10 | 台州市万福制药有限公司 | Process for synthesizing 3-acetoxy-9 beta, 10 alpha-pregna-5, 7-diene-20-ketone |
| CN102558272B (en) * | 2010-12-24 | 2014-04-23 | 中国科学院理化技术研究所 | Method for synthesizing 9-beta, 10-alpha-dehydroprogesterone ketal by photochemical isomerization reaction |
| CN102225959B (en) * | 2011-04-29 | 2012-11-07 | 中国科学院上海有机化学研究所 | 16beta-methyl-17alpha-hydroxypreg-3, 20- diketone compound and synthesis thereof |
| HUE062616T2 (en) * | 2011-09-08 | 2023-11-28 | Sage Therapeutics Inc | Neuroactive steroids, preparations and their applications |
| CN102964419A (en) * | 2012-12-11 | 2013-03-13 | 浙江仙琚制药股份有限公司 | Preparation method of compound dienogest |
| CN106279240B (en) * | 2015-06-11 | 2019-06-14 | 武汉朗来科技发展有限公司 | A method of for carbonyl-protection |
| CN110818760B (en) * | 2019-11-12 | 2021-06-25 | 广西师范大学 | A kind of production technology of industrialized synthesis of dydrogesterone |
-
2020
- 2020-03-13 CN CN202010175402.0A patent/CN113387991B/en active Active
Non-Patent Citations (1)
| Title |
|---|
| Investigations on sterols XIX: 6-Dehydro-9β, 10α-progesterone from pregnenolone;M. P. RAPPOLDT,等;《Recueil des Travaux Chimiques des Pays-Bas》;第80卷(第01期);第44页,第46页第1段,1第45页第2段、倒数第1段,第46页第2段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113387991A (en) | 2021-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113387991B (en) | Method for synthesizing dydrogesterone and compound | |
| CN110818760B (en) | A kind of production technology of industrialized synthesis of dydrogesterone | |
| CN107531746B (en) | Preparation method of 9 β,10 α -pregna-4, 6-diene-3, 20-diketone | |
| CN110330500B (en) | Stereoselective synthesis method of 6 beta-hydroxy-7, 8-dihydro-morphine derivative | |
| CN113880904B (en) | New method and compounds for synthesizing dydrogesterone | |
| ES2670477B1 (en) | Procedure for the preparation of 17beta-hydroxy-des-a-androst-9,10-en-5-one | |
| AU2003220251A1 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| CN115160395A (en) | Method for synthesizing dydrogesterone from phytosterol degradation product | |
| US6610892B2 (en) | Process for preparing 2,7-dimethyl-2,4,6-octatrienal monoacetals | |
| CN112409434B (en) | Synthesis method of dehydroprogesterone | |
| CN111944004B (en) | Preparation method of halominosone | |
| CN114380717A (en) | Process for the preparation of 3- (tert-butoxycarbonyl-methoxycarbonylmethyl-amino) -propionic acid methyl ester and intermediates thereof | |
| CN114249790A (en) | Preparation method of steroid compound | |
| CN116120387B (en) | A kind of synthesis process of dydrogesterone | |
| CN108727445B (en) | Synthesis method of azithromycin impurity F | |
| CN118878609A (en) | A green synthesis method of dydrogesterone and its intermediates | |
| CN110746471B (en) | Preparation method of fondaparinux sodium disaccharide intermediate | |
| CN117700473A (en) | Dydrogesterone intermediate and preparation method thereof | |
| CN116041358B (en) | Pranoprofen Process for the preparation of a compound containing a compound selected from the group consisting of | |
| CN111116430A (en) | Preparation method of sodium taurate | |
| CN116239645B (en) | Synthesis method of dydrogesterone | |
| CN117693501B (en) | Preparation method of cotton yellow | |
| CN112979736B (en) | Preparation method of Reidesciclovir | |
| CN117624004A (en) | Method for preparing calcitriol | |
| CN110072873A (en) | For synthesizing the industrial method of nomegestrol acetate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |